HIV Dr. Cluck EXAM 4 Flashcards

1
Q

When is a patient considered virally suppressed?

A

< 200 copies/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the main Mechanism of Transmission of HIV?

A

Sexual contact (>80%)
-MSM accounts for nearly 70%

others:
-Injection Drug Use
-Transfusion of contaminated blood or blood products
-Perinatal transmission (also known as vertical transmission or MTCT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the Rule of 3 regarding the risk of needle stick exposure to viruses?

A

HBV: 30%
HCV: 3%
HIV: 0.3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When is the latest a patient should receive prophylaxis after occupational exposure to a virus?

A

72 hours after exposure

occupational (needle stick for example)
non-occupational (sexual contact)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which antiviral drug regimen is recommended for post-exposure prophylaxis PEP?

A

TDF/FTC + Raltegravir (or DTG) for 4 weeks (within 72 hours)

TDF/FTC= Truvada
Tenofovir Disoproxil Fumarate/Emtricitabine

for Occupational and Non-occupational exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Newest data suggests which antiviral drug regimen for post-exposure prophylaxis?

A

TAF/FTC/BIC (Biktarvy) !!

-small tablet (better adherence)
-once daily

for Occupational and Non-occupational exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When should antiviral therapy be started after exposure to a virus?

A

immediately as long the patient is willing to start

“Rapid Start”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How likely is HIV transmitted from a person who has an undetectable viral load?

A

very unlikely

-U=U (undetectable = untransmittable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should be done before starting antiretroviral therapy to improve adherence?

!!!

A

-Reassure about normal life expectancy, tolerable therapy
-discuss interest in starting immediate ART
-perform a physical exam
-counsel on medication adherence !!!
-support and empower through positive messaging including U=U

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does a patient with acute HIV infection present?

A

Acute Retroviral Syndrome

-fever (80-90%)
-rash
-fatigue
-pharyngitis
-generalized lymphadenopathy (swollen lymph nodes)
-myalgia/arthralgia
-mucocutaneous ulceration (canker sores)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What lab test should be done for patients starting therapy?

A

-HIV antibody testing (to know the HIV stage)
-CD4 T-cell count (or CD4 %, to check immune function)
-Plasma HIV RNA (viral load, to see the baseline viral load))
-CBC, chemistry profile, transaminase levels,
BUN and creatinine, urinalysis, and serologies for
hepatitis A, B, and C viruses
-Fasting blood glucose and serum lipids

-genotypic resistance testing regardless of treatment plan (needs detectable viral load for the test)
-screen for other STIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If a patient fails ART, within what time frame of discontinoung the agent should they get a resistance test to isolate the virus strain?

What might happen beyond that time frame?

A

within 4 weeks of stopping the drug

-Archived Phenomen”:
it becomes harder to detect the resistant strain, bc after stopping the drug the non-resistant strain will outgrow the resistant strain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What needs to be done before starting therapy with Abacavir?

A

HLA-B*5701 test, if positive they are at risk for hypersensitive reaction (nonspecific: GI, rash, respiratory)

-Abacavir is not used often anymore, 2nd line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The Trofile assay must be done before starting which drug?

A

Maraviroc (HIV entry inhibitor)

the drug only works if the patient predominantly has R5 receptors

(expensive assay)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which test is used to monitor the response to therapy and determine the risk for opportunistic infections?

A

CD4 count (does not tell when to start therapy, (should start therapy ASAP if the patient is ready)

CD4 count < 200: risk for PJP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What other lab test is used to check for response to therapy?

A

viral load

-Integrase inhibitors are effective in reducing viral load
-the goal is to reduce viral load to undetectable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How long after starting therapy do we expect suppression of the virus?

A

12-24 weeks

-if the viral load is still high, check the patient’s adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How frequently should an HIV patient’s viral load be monitored?

A

every 3-4 months

every 6 months in stable patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When to use PrEP vs PEP

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the pharmacological difference between TAF and TDF?

A

TDF is predominantly converted into the active form TFV (tenofovir) in the plasma, rather than at the target site (PBMC)
-higher plasma concentration means more side effects, also higher dose needed

TAF conversion to TFV is mainly on the target site (PBMC), 90% less in the plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the limitations of FTC/TAF (Descovy) antiviral therapy for PrEP?

A

-not approved for cis-gender women (yet) !!! for PrEP (HIV treatment is fine?)

-not approved for on-demand dosing (taken when planning to have sexual contact)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which antiviral drug used for PrEP can be used for all genders?

A

FTC/TDF (Truvada)

-may be used with on-demand dosing (taken when having sex Vs daily) only in MSM with infrequent sex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which drugs are used for PrEP (Pre-Exposure Prophylaxis)?

A

FTC/TAF (Descovy)
FTC/TDF (Truvada)

Cabotegravir (IM every 2 months)
Lenacapavir (SC every 6 months after oral loading)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HIV treatment commonly consists of which two drug classes?

A

Integrase inhibitor (ex: raltegravir)
Nucleoside reverse transcriptase inhibitors (NRTIs)

regimen that includes Bictegravir (BIC) is often the right answer on the exam !!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Early HIV treatment

A

-recommended regardless of CD4 count
-recommended for pregnant women with early HIV infection
-can start ART before drug resistance test results are back -> DTG or protease inhibitor + 2 NRTIs to prevent resistance in this setting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What should be considered when creating a regimen for HIV patients with chronic Hep B?

A

-use a regimen with tenofovir (it covers Hep B) for chronic Hep B patients

27
Q

Antiretroviral Drug classes

A

-Nucleoside/tide reverse transcriptase inhibitors (NRTIs)
-Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
-Protease Inhibitors (PIs)
-Integrase Inhibitors (INSTIs)
-Fusion Inhibitors
-Chemokine receptor antagonists (CCR5)

-Capsid inhibitor (Lenacapavir)

28
Q

Name the Nucleoside reverse transcriptase inhibitors (NRTIs).

A

-Retrovir (zidovudine/AZT)
-Ziagen (abacavir/ABC)
-Epivir (lamivudine/3TC)
-Emtriva (emtricitabine/FTC)
-Videx EC (didanosine/ddI) - not often used, toxic

-Viread (tenofovir disoproxil fumarate or TDF)
-tenofovir alafenamide (TAF)

29
Q

Which two NRTIs should not be given together?

A

Epivir (lamivudine/3TC) and Emtriva (emtricitabine/FTC)

-because they are both cytidine analogs -> duplication

30
Q

What are the class toxicities of NRTIs?

A

-lactic acidosis (from mitochondrial toxicity)
high lactate, low pH or bicarbonate, N/V, SOB

-Hepatomegaly with steatosis (fat build-up)

31
Q

What are the toxicities specific to Retrovir (zidovudine/AZT)?

A

Anemia
neutropenia
headache
malaise

32
Q

What are the toxicities specific to Didanosine (Videx)?

A

-Non-cirrhotic portal hypertension
-pancreatitis
-CD4 toxicity with tenofovir disoproxil fumarate

33
Q

What are the toxicities specific to Abacavir?

A

Hypersensitivity
increased risk for MI?

benefit:
no renal dose adjustment

34
Q

What are the toxicities specific to Tenofovir?

A

especially with Tenofovir Disoproxil Fumarate bc higher concentrations in the plasma
-Renal dysfunction (Fanconi’s syndrome)
-Decreased bone mineral density

less with Tenofovir alafenamide, but more weight gain

35
Q

Non-NRTIs

A

-Sustiva (efavirenz/EFV)
-Viramune (nevirapine/NVP)
-Intelence (etravirine/ETR)
-Edurant (rilpivirine/RPV)
-Pifeltro (doravirine/DOR

36
Q

What are the class toxicities of Non-NRTIs?

A

-Hepatoxicity
-Rash

-CNS effects specifically with Efavirenz (Sustiva)
caution in patients with psychiatric diseases, increased suicidality, vivid dreams

37
Q

Oral Rilpivirine (Edurant) cannot be used with which drugs?

A

PPIs
long-acting formulations of Rilpivirine are fine

oral rilpivirine has to be taken with food

38
Q

Protease Inhibitors
-avir

A

-Reyataz (atazanavir/ATV) - commonly used, but can cause jaundice, icterus
-Prezista (darunavir/DRV) - most often used, mutation-resistant

-Viracept (nelfinavir/NFV)
-Invirase (saquinavir/SQV)
-Norvir (ritonavir/RTV)

-Crixivan (indinavir/IDV) - not on the market
-Kaletra (lopinavir/LPV PLUS ritonavir)
-Lexiva (fosamprenavir/FPV)

39
Q

What should be considered when using Protease inhibitors?

A

should be combined with pharmacokinetic enhancers (CYP inhibition) ritonavir or cobicistat

-watch for DDI

40
Q

What are the class side effects of Protease Inhibitors?

A

-Lipodystrophy (long-term) - mostly with ritonavir
-metabolic abnormalities (hyperglycemia and hyperlipidemia)
-morphologic abnormalities (fat atrophy and fat deposition)

41
Q

Integrase inhibitors

A

-tegravir

-Isentress/Isentress-HD (raltegravir/RAL)

-Genvoya/Stribild (elvitegravir/EVG)* - need pharmacokinetic enhancer

-Tivicay (dolutegravir/DTG)

-Biktarvy (bictegravir/BIC)* - most often used

-Cabenuva/Apretude (cabotegravir)

42
Q

Which drugs are in Genvoya/Stribild?

A

Elvitegravir/Cobicistat/Emtricitabin/Tenofovir

43
Q

Which drugs are in Biktarvy?

A

BIC, emtricitabine & tenofovir alafenamide

44
Q

What is the difference between Cabenuva and Apretude?

Integrase inhibitors?

A

Apretude = Cabotegravir (IM)
approved for PrEP

Cabenuva = Cabotegravir + rilpivirine (IM)
for HIV treatment (used to switch therapy, not for patient naive)

-> low viral load (<50) is required before switching to Cabenuva (need strong viral suppression to avoid mutation and resistance)

45
Q

Entry inhibitor

A

Selzentry (maraviroc)

46
Q

Fusion inhibitor

A

Fuzeon (enfuvirtide/T-20)

-SC
-no DDIs, but has many other issues

47
Q

Which drugs are reserved for heavily treatment-experienced patients (drug resistance, tried other agents and failed)?
What is the MOA of these drugs?

A

Attachment inhibitor
-Trogarzo (ibalizumab)
-Rukobia (fostemsavir)

Capsid inhibitor
-Sunleca (lenacapavir)

48
Q

Advantage/Disadvantage of Bictegravir

A

Advantage:
-STR once daily as Biktarvy (TAF/FTC/BIC)
-few drug and food interactions
-high barrier to resistance

Disadvantage:
-least amount of data
-only available as STR
-no safety data in pregnancy

49
Q

Advantage/Disadvantage of Dolutegravir (Trivicay)

A

Advantages
-STR once daily as Triumeq (dolutegravir/ABC/3TC)
-high barrier to resistance
-few interactions
-preferred in pregnancy (2nd, 3rd trimester)

Disadvantages:
-the STR has ABC (MI risk, hypersensitivity)
-increases metformin levels
-concerns with conception, early pregnancy

50
Q

Advantage/Disadvantage of Elvitegravir

A

Advantages
-STR with TAF/FTC/Cobicistat

Disadvantage
-many DDIs due to Cobicistat
-not recommended in pregnancy

51
Q

Advantage/Disadvantage of Raltegravir

A

Advantages
-longest experience (oldest)
-few interactions
-option for pregnant patients

Disadvantage
-multiple pills, no STR
-limited data at conception

52
Q

TAF/FTC and TDF/FTC are often used as backbone drugs for HIV treatment, what are the brand names?

A

TAF/FTC = Descovy

TDC/FTC = Truvada

53
Q

Which drug regimen should be used carefully due to DDIs?

A

Genvovy/Stribild

contains Elvitegravir -> which needs an enhancer (Cobicistat), Cobicistat has multiple DDIs

54
Q

When can a patient use Cabenuva for HIV treatment?

A

-it is used for patients who are on HIV treatment and want to switch to a simpler regimen

-need a low viral load <50 copies/ml (strong viral suppression, to avoid mutations and resistance)

55
Q

Which of the following are full regimen options for a patient who was newly diagnosed with HIV?

A. Biktarvy
B. Cabenuva
C. Descovy
D. Truvada

A

Biktarvy (right answer)

Cabenuva is not for naive patients and needs a low viral load

Descovy and Truvada by themselves are not full regimens, they only contain NRTIs -> need to add an Integrase inhibitor (dolutegravir, raltegravir)

56
Q

What are things to be cautious about in patients who receive boosted Protease inhibitor therapy?

Protease inhibitors (-avir)

A

-they need pharmacokinetic enhancers (ritonavir or cobicistat)
-DDI due to pharmacokinetic enhancers (CYP) !!!

-renal dysfunction if ritonavir or atazanavir is used with TDF

-lipid effects (hyperlipidemia, Lipodystrophy, fat atrophy), also hyperglycemia

-hyperbilirubinemia

57
Q

Which drug has a DDI with PPIs and must be given with food?

A

Oral rilpivirine (RPV)

-less effective with high viral load
-high risk for resistance

58
Q

How do Ritonavir and Cobicistat affect CYP activity?

A

Ritonavir
inhibitor of CYP3A4, 2D6 and P-glycoprotein

Cobicistat
inhibitor of CYP3A4 (may inhibit 2D6)

-avoid with corticosteroids (also nasal corticosteroids - cushioning effect (increases lvl of corticosteroid)

59
Q

Which antiretroviral agents are less preferred in renal dysfunction?

A

TDF
ATV/RTV (protease inhibitors)

60
Q

What are the most lipid neutral antiretroviral agents?

A

Raltegravir (RAL)
Dolutegravir (DTG)
Rilpivirine (RPV)

61
Q

Which antiretroviral drugs are associated with increased CV risk?

A

Abacavir (ABC) !!!

Didanosine (ddi)
Lopinavir (LVP)
Ritonavir (RTV)

62
Q

Which drug is preferred if a patient presents with HIV and Hep B?

A

Tenofovir DF (TDF) + 3TC or FTC

63
Q

What antiretrovirals are without any known drug interactions?

A

-ibalizumab
-enfuvirtide (fusion inhibitor)